| Execution period | Expected within one year, subject to approvals and statutory formalities |
|---|
BSE filing, NSE: ABANSENT. Summary written from the filing by ALFA Finder's alert engine.
Abans Enterprises Ltd: key numbers
- Share price
- ₹27.78
- Market cap
- ₹193.8 Cr
- Revenue (annual)
- ₹13,813 Cr
- Net profit (annual)
- ₹3.96 Cr
- P/E (TTM)
- 6.1×Sector 46.5×
- Promoter holding
- 74.56%+0.00% QoQ
- FII holding
- 20.62%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Abans Enterprises Ltd
All →Abans Enterprises Q2 FY27 Results: Net Profit ₹0.9 Cr, Down 81.6% YoY
Abans Enterprises Ltd reported revenue from operations of ₹1,902 Cr (-25.8% YoY) and net profit of ₹0.9 Cr (-81.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.9 Cr · -81.6% YoY
Abans Enterprises Board Meeting Date
Abans Enterprises will hold a board meeting on 4 November 2026 to consider unaudited quarterly and half-year results. No financial figures are disclosed in this notice.
Abans Enterprises Other Announcement
Abans Enterprises Ltd filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Abans Enterprises Price Movement Clarification
Abans Enterprises clarified that recent stock price movements are purely market-driven. The company confirmed no undisclosed material information exists regarding price or volume fluctuations.
Abans Enterprises Other Announcement
Abans Enterprises Ltd filed a certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026, confirming RTA compliance.
Abans Enterprises Other Announcement
Abans Enterprises has initiated the dispatch of mandatory intimations to physical shareholders to update their PAN, KYC, and nomination details as per SEBI regulations.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr
HEG Advanced Materials Merger & Restructuring Worth ₹10.12 Cr
HEG Advanced Materials closed LNJ Trading FZCO, its Dubai-based wholly owned subsidiary, as part of overseas structure rationalisation. The filing quantifies the effect at AED 4,048,000.
- Value
- ₹10.12 Cr